科研之友
微信
新浪微博
Facebook
分享链接
摘要
A literature based study on the health impacts of three platinum anticancer drugs (cisplatin, carboplatin and oxaliplatin) was undertaken. The published evidence for health benefits is presented and assessed. A model was developed to quantify the health gain of adding platinum based drugs to cancer treatment at the population level for the UK and the USA. The economic value of using platinum drugs (in terms of quality-adjusted life year (QALY)) in addition to other cancer treatments can be estimated at over 556 pound million for the UK and over US$4.8 billion for the USA, depending on the scenario chosen.
- 出版日期2017-1
